Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bluebird Bio
(NQ:
BLUE
)
0.9871
-0.0229 (-2.27%)
Streaming Delayed Price
Updated: 3:30 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bluebird Bio
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
bluebird bio Provides Update on Upcoming Planned Business Separation
October 08, 2021
From
bluebird bio, Inc.
Via
Business Wire
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...
Via
Benzinga
SVB Leerink Says 'We Were Wrong,' Slashes Bluebird Bio Price Target
August 09, 2021
After the
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
Bluebird Bio Files US Application For β-thalassemia Gene Therapy
September 22, 2021
Bluebird Bio Inc (NASDAQ: BLUE) completed the rolling submission of its marketing application to the FDA seeking approval for betibeglogene autotemcel (beti-cel)...
Via
Benzinga
Exposures
Product Safety
bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood Cell Transfusions
September 21, 2021
From
bluebird bio, Inc.
Via
Business Wire
2seventy bio Announces Upcoming Investor Events
September 13, 2021
From
bluebird bio
Via
Business Wire
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
bluebird bio Secures $75 Million in Private Placement Equity Financing
September 08, 2021
From
bluebird bio, Inc.
Via
Business Wire
bluebird bio Announces Key Management and Board Appointments and Upcoming Investor Events
September 07, 2021
From
bluebird bio, Inc.
Via
Business Wire
The Latest Barron's Picks And Pans Include General Electric, Netflix, Reddit And More
September 04, 2021
This weekend's Barron's reveals what market strategists recommend for a stock market that likely will struggle this fall. Other featured articles discuss biotech stocks...
Via
Benzinga
3 Beaten-Down Biotech Stocks to Buy Right Now
August 18, 2021
These biotech stocks might be down, but they're not out.
Via
The Motley Fool
BLUEBIRD BIO INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of bluebird bio, Inc. - BLUE
August 13, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows. Key Facts: PACCAR (NASDAQ:PCAR) was the biggest company by market cap to set a new 52-week low....
Via
Benzinga
Why Bluebird Bio's Stock Is Trading Lower Today
August 09, 2021
Bluebird Bio Inc (NASDAQ: BLUE) is trading lower Monday after the company reported worse-than-expected second-quarter financial results and announced that the FDA placed...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
COVID-19
68 Biggest Movers From Yesterday
August 10, 2021
Gainers Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) shares climbed 50.8% to close at $18.50 on Monday after the company and DraftKings announced they entered into a...
Via
Benzinga
Bluebird Stock Crashes To 7-Year Low After FDA Pauses Gene Therapy Test
August 09, 2021
Bluebird Bio said Monday the FDA paused one of its gene therapy studies due to safety concerns, and BLUE stock collapsed.
Via
Investor's Business Daily
Exposures
Product Safety
Why Bluebird Bio Stock Is Crashing Today
August 09, 2021
The drugmaker had a double whammy of bad news.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
August 09, 2021
Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 33.66% to $4.3 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 87.6...
Via
Benzinga
Bluebird Bio's Shares Drop To 52-Week Low After Another Gene Therapy Trial Placed On FDA Hold
August 09, 2021
Shares for Bluebird Bio Inc (NASDAQ: BLUE) is hovering at a 52-week low after the FDA placed a clinical hold on clinical studies of elivaldogene autotemcel (...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 09, 2021
Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 30.38% to $2.36 during Monday's pre-market session. The company's market cap stands at $61.9 million. The...
Via
Benzinga
Recap: bluebird bio Q2 Earnings
August 09, 2021
Shares of bluebird bio (NASDAQ:BLUE) moved higher by 0.9% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 852.78...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 09, 2021
Before 10 a.m. ET Monday, 63 stocks made new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was PACCAR (NASDAQ:PCAR)....
Via
Benzinga
bluebird bio Reports Second Quarter Financial Results and Provides Operational Update
August 09, 2021
From
bluebird bio, Inc.
Via
Business Wire
bluebird bio Announces Q2 Earnings Call and Upcoming Investor Events
August 05, 2021
From
bluebird bio, Inc.
Via
Business Wire
bluebird bio, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2021
From
bluebird bio, Inc.
Via
Business Wire
Is This Small-Cap Biotech a Buy After Its Second Approved Gene Therapy?
August 03, 2021
After receiving yet another treatment approval from regulators, Bluebird Bio looks like a bargain.
Via
The Motley Fool
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.